TURCHETTI, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 40.726
NA - Nord America 36.726
AS - Asia 20.038
SA - Sud America 3.551
Continente sconosciuto - Info sul continente non disponibili 556
AF - Africa 480
OC - Oceania 87
AN - Antartide 1
Totale 102.165
Nazione #
US - Stati Uniti d'America 35.043
NL - Olanda 15.151
SG - Singapore 7.219
IT - Italia 6.607
RU - Federazione Russa 5.437
CN - Cina 5.067
GB - Regno Unito 4.682
VN - Vietnam 2.845
BR - Brasile 2.829
DE - Germania 2.384
UA - Ucraina 1.996
DK - Danimarca 1.241
CA - Canada 1.238
HK - Hong Kong 1.140
KR - Corea 1.074
FR - Francia 880
BD - Bangladesh 798
SE - Svezia 564
IN - India 460
FI - Finlandia 408
IE - Irlanda 349
PL - Polonia 313
AR - Argentina 268
MX - Messico 245
ES - Italia 172
ZA - Sudafrica 170
ID - Indonesia 167
TR - Turchia 167
JP - Giappone 164
IQ - Iraq 151
EC - Ecuador 130
EU - Europa 126
IL - Israele 101
PK - Pakistan 89
AT - Austria 86
CO - Colombia 80
PH - Filippine 76
AU - Australia 75
VE - Venezuela 72
MA - Marocco 66
MY - Malesia 64
BE - Belgio 62
CH - Svizzera 62
SA - Arabia Saudita 60
UZ - Uzbekistan 59
LT - Lituania 56
CL - Cile 50
PE - Perù 46
JM - Giamaica 41
PT - Portogallo 41
JO - Giordania 40
AE - Emirati Arabi Uniti 39
PY - Paraguay 38
EG - Egitto 36
TN - Tunisia 34
KE - Kenya 32
TW - Taiwan 32
CR - Costa Rica 31
RO - Romania 30
TH - Thailandia 30
IR - Iran 25
AZ - Azerbaigian 24
BG - Bulgaria 23
NP - Nepal 23
HN - Honduras 22
AL - Albania 21
DO - Repubblica Dominicana 21
ET - Etiopia 21
SK - Slovacchia (Repubblica Slovacca) 20
DZ - Algeria 19
KZ - Kazakistan 18
CZ - Repubblica Ceca 17
SN - Senegal 17
UY - Uruguay 17
GR - Grecia 16
NI - Nicaragua 16
HU - Ungheria 15
TT - Trinidad e Tobago 15
NG - Nigeria 14
RS - Serbia 14
BO - Bolivia 13
CI - Costa d'Avorio 13
CY - Cipro 13
HR - Croazia 13
ML - Mali 13
LV - Lettonia 12
OM - Oman 12
PA - Panama 12
PS - Palestinian Territory 12
BA - Bosnia-Erzegovina 11
NZ - Nuova Zelanda 11
AO - Angola 10
GT - Guatemala 10
LB - Libano 10
BY - Bielorussia 8
GE - Georgia 8
MD - Moldavia 8
SI - Slovenia 8
GH - Ghana 7
KG - Kirghizistan 7
Totale 101.602
Città #
Amsterdam 14.944
Dallas 6.218
Singapore 3.772
Southend 3.055
Ashburn 2.482
San Jose 2.207
Beijing 2.118
Chandler 2.063
Woodbridge 1.736
Houston 1.579
Ann Arbor 1.350
San Mateo 1.164
Hong Kong 1.092
Milan 1.017
Moscow 956
Jacksonville 950
Dearborn 841
Daejeon 815
Fairfield 780
The Dalles 761
Ho Chi Minh City 742
Rome 657
Falls Church 629
Los Angeles 608
Cambridge 603
Wilmington 575
Pisa 572
New York 541
Council Bluffs 531
Hanoi 489
Seattle 460
Hefei 408
Dong Ket 397
Lauterbourg 394
Stevenage 379
Boardman 372
Santa Clara 364
Portsmouth 357
Montréal 339
Lawrence 325
São Paulo 324
Dublin 321
Warsaw 267
Munich 264
Buffalo 250
Seoul 247
Brooklyn 235
Beauharnois 228
Fremont 191
Columbus 187
Orem 186
Ottawa 177
Montreal 169
Figino 153
Redwood City 147
Chicago 139
London 136
Denver 134
Chennai 130
Old Bridge 130
Salerno 130
Atlanta 126
Tokyo 126
Mexico City 119
Florence 114
Stockholm 112
Johannesburg 111
Toronto 110
Turin 110
Da Nang 104
Helsinki 102
San Diego 102
Poplar 100
Mcallen 91
Phoenix 90
Bologna 86
Frankfurt am Main 85
Rio de Janeiro 84
Naples 83
Haiphong 82
Tel Aviv 77
San Francisco 75
Manchester 73
Nuremberg 71
Boston 66
Guangzhou 65
Ankara 62
Norwalk 59
Wuxi 57
Brasília 53
Serra 53
Tashkent 53
Biên Hòa 52
Belo Horizonte 51
Mumbai 50
Guayaquil 49
Palermo 46
Shanghai 46
Baghdad 45
Paris 45
Totale 66.872
Nome #
L’Economia digitale e il settore assicurativo 2.120
The interaction of public and private systems in healthcare provision 2.049
Il Costo Sociale della Malattia di Alzheimer 2.012
Il governo delle tecnologie per un ammodernamento del Sistema Sanitario 2.009
Il Costo Sociale dell’Emicrania 2.007
La qualità della vita di soggetti anziani nelle grandi città e nei piccoli paesi: uno studio comparato sui bisogni dei cittadini in Italia ed in Giappone 2.006
L’E-Commerce. Le Nuove Frontiere della Distribuzione Assicurativa 2.001
Prevenzione delle cadute da incidente domestico negli anziani 1.999
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 886
Nutri-Score and Food Perception: Insights from an Italian Study 795
A cost-effectiveness analysis for total knee arthroplasty telerehabilitation: proof of concept of a decision model 586
On Robots and Insurance 576
The Effect of using Serifs in Brand Names on Luxury Perception 534
PDTA per la Chirurgia bariatrica: l'esperienza di sei centri italiani 518
A new organizational integrated home-care model: An Italian pilot study 514
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 512
The impact of cardiovascular disease and type 2 diabetes mellitus on social cost in chronic kidney disease patients in Italy 461
How deregulation shapes market structure and industry efficiency. The case of the Italian motor insurance industry 453
Economic evaluation of da Vinci-assisted robotic surgery:a systematic review 446
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 418
A budget impact analysis (BIA) of the use of paracalcitol for the treatment of a secondary hyperparathyroidism (SHPT) in end stage renal disease patients 409
La logistica sanitaria nelle Aziende Sanitarie e Ospedaliere del Servizio Sanitario Nazionale 406
Acceptability of robotic technology in neuro-rehabilitation: Preliminary results on chronic stroke patients 398
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 394
Early Stage Economic Evaluation of Caretoy System for Early Intervention In Preterm Infants At Risk of Neurodevelopmental Disorders 390
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 378
Cost-effectiveness (CE) of imaging-guided strategies for the diagnosis of coronary artery disease (CAD): results from the EVINCI study 375
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 371
Early assessment of neuro-rehabilitation technology: a case study 348
Marketing per la Sanità. Logiche e strumenti 348
Comparative health technology assessment of robotic-assisted, direct manual laparoscopic and open surgery: a prospective study 345
Budget impact analysis of belimumab in treating Systemic Lupus Erythematosus 341
Health technology assessment. Evaluation of biomedical innovative technologies 339
Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF 336
A Pitcure of Private Health Insurance Policyholders in Italy 334
How colour saturation accelerates purchase behaviour, and influences food choice: 331
Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis 331
Scoping review and bibliometric analysis of Big Data applications for Medication adherence: An explorative methodological study to enhance consistency in literature 328
Cost analysis of the robotic surgery in Italy 327
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 327
Early assessment of neuro-rehabilitation technology 322
The opportunity of treating type II diabetes with DPP4i: an economic evaluation versus conventional treatment in the Italian setting 322
Model-Based Techniques In The Early Phases of The Medical Device Development: A Systematic Literature Review 322
Tele-monitoring of ventilator-dependent patients: A European Respiratory Society Statement 321
A systematic literature review of the economic impact of ankylosing spondylitis 317
Early assessment of neuro – rehabilitation technology: a case study 316
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 316
Effectiveness and costs of different strategies for the diagnosis of stable coronary artery disease: results from the EVINCI study 313
Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis 311
An economic evaluation of different procedures in bariatric surgery 311
Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies 311
A novel explanation of why organizations fail to adopt proven technologies: The special case of imaging in the healthcare sector 310
Interactive business models for Telerehabilitation after Total Knee Replacement: Preliminary results from Tuscany 307
A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus 306
Social costs of different procedures in bariatric surgery in patients with obesity-related comorbidities 304
Is EEG Suitable for Marketing Research? A Systematic Review 304
Health Technology Assessment Needs Information Technology: The Experience From The First Italian Study On The Da Vinci Surgical Robot 303
Assessment of the economic impact of Belimumab for the treatment of systemic lupus erithematosus in the Italian setting: a cost-effectiveness analysis 301
Economic evaluation of the acquisition of a remote monitoring system in the framework of a 'chronic care model' 299
Topic modeling and user network analysis on twitter during world lupus awareness day 298
Economia e gestione delle imprese di assicurazione 297
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 297
Budget impact analysis of the use of extended half-life recombinant factor VIII (Efmoroctog alfa) for the treatment of congenital haemophilia A: The Italian national health system perspective 297
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 296
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 295
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 295
A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools 294
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 293
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 292
Analisi di budget impact sull’utilizzo di paracalcitolo nel trattamento dell’iperparatiroidismo secondario associato a malattia renale cronica 291
Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study 289
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 288
A registry for the collection of data in cochlear implant patients 288
Belimumab nel trattamento del Lupus Eritematoso Sistemico: valutazione di una nuova tecnologia sanitaria 288
The COVID-19 outbreak: From “black swan” to global challenges and opportunities 287
Innovation in rehabilitation technology 286
Natural and man-made disasters: challenges and international perspectives for insurance 285
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 284
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 283
Economic impact of drug addiction interventions in adult population: The Peru case 282
Late chronotypes, late mealtimes. Chrononutrition and sleep habits during the COVID-19 lockdown in Italy 281
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 280
Assessing the value of the use of diagnostic technology: trade offs for GPs 276
2023 update on Italian guidelines for the treatment of type 2 diabetes 274
Alfonso Desiata. L'Assicuratore, l'Intellettuale, la Persona 274
Early timing of the use of paricalcitol for the treatment of secondary hyperparathyroidism (SHPT) in chronic kidney patients (CKD): a budget impact analysis (BI) 274
Do Socioeconomic Inequalities Impact The Social Cost Of Chronic Kidney Disease In Italy? 272
Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: The Italian National Health System perspective 272
Adherence to treatment in Behçet's syndrome: a multi-faceted issue 272
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 271
The quality of life of patients treated with robotic versus traditional surgery: results from an Italian observational multicenter study 270
Evidence-gathering across industry and academia on early Health Technology Assessment (HTA) of medical devices: survey design and piloting 267
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 267
Dentro, attraverso, oltre la crisi: il caso El.En 266
Cost-effectiveness of Different Strategies for the Diagnosis of Stable Coronary Artery Disease: Results from the Evinci Study 266
Sleep quality mediates the effect of chronotype on resilience in the time of COVID-19 266
Il Governo della Sanità 265
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 265
Post-traumatic stress disorder and post-traumatic stress symptoms in patients with systemic autoimmune diseases during the COVID-19 pandemic 264
Allocazione delle Risorse al Sistema della Ricerca e Competitività del Sistema delle Imprese: una Chiave di Lettura 264
Totale 47.485
Categoria #
all - tutte 445.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 445.506


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.492 0 871 157 297 95 95 609 997 311 480 146 434
2022/20234.347 366 365 139 759 552 736 28 338 645 99 185 135
2023/20242.071 230 107 335 92 70 271 220 115 79 75 132 345
2024/202513.881 160 164 856 465 537 1.088 2.179 3.849 1.179 566 1.896 942
2025/202652.246 1.956 5.594 4.216 4.334 4.131 2.434 4.581 1.615 16.823 2.381 1.648 2.533
2026/2027880 809 71 0 0 0 0 0 0 0 0 0 0
Totale 102.165